Case study of a 2022 pertussis epidemic in the Baoro sub-prefecture (Central African Republic) - 15/11/23
, C. Lakei-Abdon b, P. Wol-Wol c, C.M. Pamatika d, M.R. Belizaire eHighlights |
• | The disease predominantly affects rural areas (50.35%), in which vaccinations are fewer; |
• | The age groups from 12 to 59 months were most affected (58.16%); |
• | The majority of patients were female (54.55%); |
• | Pertussis vaccination had a protective effect, with vaccine efficacy of 38.67%. |
Abstract |
Objective |
The objective of this survey was to describe epidemiological characteristics and evaluate vaccine effectiveness against pertussis in the sub-prefecture of Baoro (Central African Republic).
Method |
We conducted a case control study from June to July 2022 in the sub-prefecture of Baoro in the district of Baour-Baoro. Community-based definitions of surveillance were applied to include cases and controls.
Results |
All in all, 143 confirmed and suspected cases and 166 controls were enrolled in this investigation. The epidemic had affected 12 neighborhoods and 9 villages. The village of Bugbassem alone had 32 patients, and 50% of the patients lived in rural areas. The age groups of 12 to 59 months accounted for 58% of cases. Patients were female in 54% of cases (p = 0.8). The attack rate among unvaccinated patients (65%) was higher than that of vaccinated patients (40%), while 15% (N = 21) of children were hospitalized with no recorded deaths. Pentavalent 3rd dose vaccination coverage was 49% in controls versus 33% in cases. Vaccination provided a significant protective effect (Odds Ratio = 0.3; 95% CI: 0.2–0.6). All told, vaccine efficacy against pertussis was 38%.
Conclusion |
Pertussis is a re-emerging disease currently occurring as a result of low pertussis vaccination coverage. It strongly affects rural areas with low vaccination rates. Vaccination strategy requires reinforcement in rural areas.
Le texte complet de cet article est disponible en PDF.Keywords : Baoro, Pertussis, Vaccine efficacy, Epidemic, CAR
Plan
Vol 53 - N° 8
Article 104778- octobre 2023 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
